Prolonged survival of a leukemic patient in a protected environment.
D000328:Adult; D000380:Agranulocytosis / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification; D004423:Ear / Q000382:microbiology; D004755:Enterobacteriaceae / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D006801:Humans; D017053:Infection Control; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy*; D008297:Male; D009666:Nose / Q000382:microbiology; D010357:Patient Isolators; D010614:Pharynx / Q000382:microbiology; D013997:Time Factors; D014556:Urine / Q000382:microbiology
D000900:Anti-Bacterial Agents